Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 70 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
First-line Treatment Options for PD-L1-negative Lung Adenocarcinoma: a Real-World Analysis
Lijuan Chen,Jie Liu, Junfeng Lu,Xiufeng Hu, Erjing An, Yanqiu Zhao
Frontiers in Oncology (2025)
Cited0Views0Bibtex
0
0
Combined Therapy with DR5-targeting Antibody-Drug Conjugate and CDK Inhibitors As a Strategy for Advanced Colorectal Cancer
Dongdong Zhou, Er'jiang Tang, Wenjun Wang, Youban Xiao, Jianming Huang,Jie Liu, Chao Zheng, Kai Zhang, Ruxia Hu, Feiqi Wang,Peng Xiong, Xin Chu, Weisong Li, Dongqin Liu, Xiangfu Zeng,Dexian Zheng,Liefeng Wang, Yong Zheng,Shuyong Zhang
Cell reports Medicinepp.102158-102158, (2025)
Cited0Views0WOSBibtex
0
0
Antitumor Activity of Gilteritinib, an Inhibitor of AXL, in Human Solid Tumors
Zuxiong Zhang, Ruxia Hu,Jie Liu, Xiaohan Yang, Youban Xiao, Xi Xu, Xinxin Liu,Wen Zeng,Shuyong Zhang,Liefeng Wang
Cell death discoveryno. 1 (2025): 124-124
Cited0Views0WOSNATUREBibtex
0
0
Load More
Author Statistics

#Papers: 70

#Citation: 1109

H-Index: 20

G-Index: 32

Sociability: 6

Diversity: 3

Activity: 15

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn